Susquehanna International Group
RVLP

Susquehanna International Group’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Susquehanna International Group’s Portfolio RVLP Stock Details RVLP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-31,006
Closed -$2.69K – 13722
2023
Q3 		$2.69K Buy
+31,006
New +$8.94K ﹤0.01% 11827
2023
Q2 		– Sell
-127,853
Closed -$146K – 13557
2023
Q1 		$146K Buy
127,853
+6,947
+6% +$8.34K ﹤0.01% 10933
2022
Q4 		$135K Buy
120,906
+106,243
+725% +$169K ﹤0.01% 10640
2022
Q3 		$31K Buy
+14,663
New +$28.5K ﹤0.01% 12435
2022
Q2 		– Sell
-10,954
Closed -$15.9K – 14318
2022
Q1 		$19K Buy
+10,954
New +$15.7K ﹤0.01% 12642

Other funds holding RVLP

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Susquehanna International Group's RVLP Position: Q4 2023 in Review

Susquehanna International Group sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q4 2023, closing a stake of 31,006 shares — an estimated $2.69K sold.

Susquehanna International Group first reported a position in RVLP in Q1 2022 and held it in 5 quarters. The position peaked at $146K in Q1 2023. 3 funds tracked by Wall St. Rank hold RVLP as of Q4 2023.

  • Susquehanna International Group reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Susquehanna International Group sold 31,006 RVL Pharmaceuticals plc Ordinary Shares shares in Q4 2023, an estimated $2.69K.
  • Susquehanna International Group first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q1 2022 and held it in 5 quarters.
  • Susquehanna International Group's RVL Pharmaceuticals plc Ordinary Shares position peaked at $146K in Q1 2023.
  • 3 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q4 2023.

Based on Susquehanna International Group's 13F filing for Q4 2023, filed 14 Feb 2024.